Sign in
CompletedNo phase

Effect Of Pulmonary Rehabilitation in Patients With Alpha-1 Antitrypsin Deficiency

Key facts

Who runs it
University of Parma
Where
Italy1 site in 1 countryChoose a country to see its sites
Trial code
Status
Completed
People taking part
50 people enrolled
Started
15 Nov 2024
Ended
24 Jun 2025
Type of study
Observational
Treatments tested
  • Pulmonary Rehabilitation
Record updated
21 November 2025

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part
Show the full registry criteria (4)Hide the full registry criteria

Who can take part

  • Male or female adults aged ≥18 years
  • Signed informed consent
  • All AATD patients, regardless of nephelometric alpha-1 antitrypsin dose and clinical phenotype, who require PR according to guidelines

Who cannot take part

  • Subjects unable to perform the lung function tests and rehabilitation program required by the protocol

Where is this trial?

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

This single-center, longitudinal, observational, prospective study aims to assess the applicability, adherence, and clinical impact of the Active Cycle of Breathing Technique (ACBT) with augmented reality support in patients with alpha-1 antitrypsin deficiency (AATD).

Read full original descriptionShow less

A total of 50 adult AATD patients will be recruit from the Lung Function Unit of the University Hospital of Parma, meeting specific inclusion criteria. Participants will perform ACBT twice daily and walk at least 5000 steps per day. Clinical and functional outcomes including dyspnea perception, lung function, and quality of life, will be assessed before and after a six-week ACBT program.

The study explores whether augmented reality enhance adherence and efficacy compared to conventional pulmonary rehabilitation (PR) methods. The expected outcome is improved adherence to PR.

The group in the trial

  • Patients with alpha-1 antitrypsin deficiency (AATD)

    Adults with a confirmed diagnosis of alpha-1 antitrypsin deficiency (AATD) with asthma and/or COPD.

    Treatment: Pulmonary Rehabilitation

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Effect of Pulmonary Rehabilitation and Physical Activity in Patients With Alpha-1 Antitrypsin Deficiency
Record updated
21 November 2025